Bacha, J.; Mayalla, B.; Chodota, M., et. al.,
(Journal of the International AIDS Society., 2021)
Efficacy and safety data of novel antiretrovirals, such as dolutegravir (DTG), in children and adolescents, often lags behind adult data, and can lead to hesitation and slow uptake by HIV clinicians. Beginning in 2019, the ...